JENNIFER LANZ: Open Payments
NPI 1114343225 · NORMAL, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,273 in 69 payments from 15 companies in 2025. Trend: 2023 $851 · 2024 $938 · 2025 $1,273
Food & beverage: $1,273
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 31 | $178 |
| Amgen Inc. | 6 | $160 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $155 |
| SCPHARMACEUTICALS INC. | 3 | $144 |
| PFIZER INC. | 6 | $128 |
| Stryker Corporation | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| Novo Nordisk Inc | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Medtronic, Inc. | 1 | $36 |
Products named: LEQVIO, REPATHA, LifeVest, FUROSCIX, VYNDAQEL, FARXIGA, Wegovy, CAMZYOS.
Industry payments across IL — which companies pay providers there.
